[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Merck Kgaa (MRK.D.DX)

Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Merck Kgaa Frankfurter Strasse 250 Darmstadt HE 64293 DEU

P: +49 6151720

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Key Statistics

Overview:

Market Capitalization, $K 47,738,611
Shares Outstanding, K 434,778
% of Institutional Shareholders 16.82%

Financials:

Annual Sales, $ 21,102 M
Annual Net Income, $ 2,608 M
Last Quarter Sales, $ 5,249 M
Last Quarter Net Income, $ 319,000 K

Growth:

1-Year Return -10.57%
3-Year Return -31.11%
5-Year Return -23.52%
5-Year Revenue Growth 3.77%
5-Year Earnings Growth 5.60%
5-Year Dividend Growth 11.10%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 6.00
EPS Growth vs. Prev Year -6.25%
Annual Dividend & Yield (Paid) 2.20 (1.97%)
Annual Dividend & Yield (Fwd) 2.20 (1.97%)
Most Recent Dividend 2.200 on 04/27/26
Next Ex-Dividends Date 04/27/26
Dividend Payable Date 04/29/26
Dividend Payout Ratio 36.67%
Most Recent Split 2-1 on 06/30/14

MRK.D.DX Ratios

Ratio
Price/Earnings ttm 18.64
Price/Earnings forward 13.81
Price/Earnings to Growth 1.59
Return-on-Equity % 8.92%
Return-on-Assets % 5.06%
Profit Margin % 12.36%
Debt/Equity 0.38
Price/Sales 2.30
Price/Cash Flow 12.37
Price/Book 1.70
Book Value/Share 65.76
Interest Coverage 9.57
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.